Loading...
An evidence-based practice-oriented review focusing on canagliflozin in the management of type 2 diabetes
Caring for patients with type 2 diabetes mellitus (T2DM) has entered an era with many recent additions to the regimens used to clinically control their hyperglycemia. The most recent class of agents approved by the Food and Drug Administration (FDA) for T2DM is the sodium–glucose-linked transporter...
Na minha lista:
| Udgivet i: | Vasc Health Risk Manag |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5322811/ https://ncbi.nlm.nih.gov/pubmed/28255241 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S105721 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|